Investigating the pain-relieving effects of minor cannabinoids and terpenes from cannabis
Analgesic efficacy of single and combined minor cannabinoids and terpenes
This study is looking at how different parts of the cannabis plant can help reduce pain, especially for people dealing with chemotherapy or dental problems, and how they work alongside common pain medications like morphine.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10661039 on NIH RePORTER |
What this research studies
This research aims to explore how specific components of the cannabis plant, particularly minor cannabinoids and terpenes, work together to alleviate pain. The study will use rodent models to assess the effectiveness of these compounds in preventing pain related to chemotherapy and dental issues. Additionally, it will evaluate how these cannabis components interact with traditional pain medications like morphine. By understanding these interactions, the research seeks to identify new pain management strategies that could be beneficial for patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing chronic pain, particularly those related to chemotherapy or dental procedures.
Not a fit: Patients who do not experience pain or those with conditions unrelated to the types of pain being studied may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer pain management options for patients suffering from various types of pain.
How similar studies have performed: While there is growing interest in the analgesic properties of cannabis, this specific combination of minor cannabinoids and terpenes is relatively novel and has not been extensively tested in clinical settings.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Ward, Sara J — Temple Univ of the Commonwealth
- Study coordinator: Ward, Sara J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.